Icelea
Fixed-dose combination of antiretrovirals for the treatment of adult and adolescent patients aged ≥12 years (≥35 kg) with HIV-1. Used as part of a combination treatment regimen. Its composition results in lower long-term bone and renal impact.
Therapeutic Area
HIV + Infectology
Active Ingredient
Emtricitabine
Line
Anti-infectives + HIV - Antivirals
Dosage forms
30 coated tablets containing TAF 25mg/embricitabine 200mg
